Interviews
View More
The Economic Burden of Hemophilia B From a Payer Perspective

Dr Steven Pipe delves into the economic burden associated with Hemophilia B treatment, including costs and payer considerations.

Defining Unbranded Biologics

Distinctions between unbranded biologics, branded biologics, and biosimilars are explored by David Charles, MD.

Considering DTx and PDTs as Part of Treatment

Arwen Podesta, MD; Timothy Aungst, PharmD; and Scottle Whittle, MD, explain the considerations they think about before using or prescribing DTx and PDTs.

Understanding DTx and PDTs

A distinguished panel provides an overview of what digital therapeutics (DTx) and prescription digital therapeutics (PDTs) are and how they’re used in behavioral health treatment.

An Overview of Hemophilia B

Steven Pipe, MD, defines Hemophilia B and its standard of care.

How Tech-Driven Solutions, CMS Proposed Rule Can Save Rural Medicaid Members

In this second part of a two-part video series, Nathan Allen, Senior Vice President – Healthcare Provider Solutions at Firstsource, discusses Medicaid Redetermination for those who are Medicaid members, but are deemed to lose their coverage due to the upcoming expiration of COVID-19’s Public Health Emergency. Allen set a scope on Medicaid populations in rural settings and how they could be affected. However, there is hope through tech-based solutions and a proposed rule by CMS to prevent facility closures and preserve access to care for all affected Medicaid populations.

Medicaid Redetermination Solutions for Members Deemed to Lose Coverage From PHE Expiration

Nathan Allen, Senior Vice President – Healthcare Provider Solutions at Firstsource, discusses Medicaid Redetermination for those who are Medicaid members, but are deemed to lose their coverage due to the upcoming expiration of COVID-19’s Public Health Emergency.

Overview and Prevalence of Biologics

Dr David Charles, MD, opens a discussion surrounding the increasing usage and unique characteristics of biologics.

How Price Transparency Can Bring Efficiency Into Healthcare, per Matt Parker of Kyruus and HealthSparq

MHE spoke with Matt Parker, vice president of Products at Kyruus and HealthSparq, about the recent price transparency rules that recently went into effect and how they can bring efficiency into care.

Official Media Partners

PBMI logo

Join the Community

an mjh life sciences brand

© 2022 MJH Life Sciences and PBMI. All rights reserved.